OCUL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.30%

Insider Buying (Last 12 Months): $69,600.00

Insider Selling (Last 12 Months): $1,220,159.39

Ocular Therapeutix Insider Trading History Chart

Ocular Therapeutix Share Price & Price History

^$12.43

▲ +0.97 (8.46%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Ocular Therapeutix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/8/2025	Todd Anderman	Insider	Sell	11,132	$12.34	$137,368.88	87,568
10/2/2025	Jeffrey S. Heier	Insider	Sell	10,502	$11.04	$115,942.08	249,409
10/2/2025	Peter Kaiser	Insider	Sell	9,653	$11.03	$106,472.59	194,440
9/2/2025	Donald Notman	Insider	Sell	1,066	$12.43	$13,250.38	308,807
8/25/2025	Jeffrey S. Heier	Insider	Sell	3,063	$12.04	$36,878.52	259,911
8/25/2025	Peter Kaiser	Insider	Sell	3,011	$12.04	$36,252.44	204,093
8/25/2025	Pravin Dugel	Insider	Sell	21,494	$12.04	$258,787.76	3,227,244
8/25/2025	Sanjay Nayak	Insider	Sell	1,885	$12.04	$22,695.40	279,738
5/23/2025	Jeffrey S. Heier	Insider	Sell	3,024	$7.18	$21,712.32	262,974
5/23/2025	Peter Kaiser	Insider	Sell	2,974	$7.17	$21,323.58	207,104
5/23/2025	Pravin Dugel	Insider	Sell	21,219	$7.18	$152,352.42	3,499,099
5/23/2025	Sanjay Nayak	Insider	Sell	1,862	$7.17	$13,350.54	281,623
5/8/2025	Richard L. Lindstrom	Director	Buy	10,000	$6.96	$69,600.00	172,704
2/24/2025	Pravin Dugel	Insider	Sell	21,475	$6.87	$147,533.25	3,520,318
2/4/2025	Donald Notman	Insider	Sell	11,119	$7.81	$86,839.39	193,444
1/31/2025	Donald Notman	Insider	Sell	6,301	$7.84	$49,399.84	204,563
11/25/2024	Jeffrey S. Heier	Insider	Sell	2,948	$9.01	$26,561.48	269,059
8/23/2024	Sanjay Nayak	Insider	Sell	1,832	$9.02	$16,524.64	176,194
5/23/2024	Sanjay Nayak	Insider	Sell	2,274	$5.84	$13,280.16	178,026
2/26/2024	Summer Road Llc	Major Shareholder	Buy	930,851	$7.52	$6,999,999.52	8,591,401
1/31/2024	Antony C. Mattessich	CEO	Sell	18,338	$4.95	$90,773.10	427,943
1/31/2024	Donald Notman	CFO	Sell	6,433	$4.95	$31,843.35	139,932
1/31/2024	Philip C Strassburger	General Counsel	Sell	6,831	$4.95	$33,813.45	109,218
1/31/2024	Rabia Gurses Ozden	Insider	Sell	7,764	$4.95	$38,431.80	92,767
8/30/2023	Antony C. Mattessich	CEO	Buy	6,500	$3.81	$24,765.00	6,500
7/7/2023	Rabia Gurses Ozden	Insider	Sell	832	$4.93	$4,101.76	100,531
2/6/2023	Antony C. Mattessich	CEO	Sell	19,669	$4.24	$83,396.56	446,281
2/6/2023	Christopher G White	Insider	Sell	5,829	$4.24	$24,714.96	94,766
2/6/2023	Donald Notman	CFO	Sell	6,476	$4.24	$27,458.24	139,387
2/6/2023	Philip C Strassburger	General Counsel	Sell	6,181	$4.24	$26,207.44	109,071

SEC Filings (Institutional Ownership Changes) for Ocular Therapeutix (NASDAQ:OCUL)

59.21% of Ocular Therapeutix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ocular Therapeutix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2025	Cantor Fitzgerald L. P.	201,865	$2.36M	0.0%	N/A	0.095%
11/21/2025	CIBC Bancorp USA Inc.	14,985	$0.18M	0.0%	N/A	0.007%
11/20/2025	Maven Securities LTD	100,000	$1.17M	0.0%	N/A	0.047%
11/19/2025	Second Line Capital LLC	402,467	$4.71M	1.0%	+4.4%	0.189%
11/17/2025	CANADA LIFE ASSURANCE Co	31,914	$0.40M	0.0%	+17.4%	0.015%
11/17/2025	Woodline Partners LP	1,666,087	$19.48M	0.1%	+121.9%	0.782%
11/17/2025	TCG Crossover Management LLC	6,117,232	$71.51M	3.5%	+15.0%	2.871%
11/17/2025	Dark Forest Capital Management LP	83,439	$0.98M	0.0%	-48.5%	0.039%
11/17/2025	Voleon Capital Management LP	33,203	$0.39M	0.0%	N/A	0.016%
11/17/2025	Verition Fund Management LLC	166,033	$1.94M	0.0%	+11.7%	0.078%
11/17/2025	Scientech Research LLC	17,269	$0.20M	0.1%	N/A	0.008%
11/17/2025	Quarry LP	6,870	$80K	0.0%	N/A	0.003%
11/17/2025	Qube Research & Technologies Ltd	30,852	$0.36M	0.0%	N/A	0.014%
11/17/2025	Paradigm Biocapital Advisors LP	3,497,307	$40.88M	1.2%	+2.3%	1.642%
11/17/2025	Millennium Management LLC	3,855,706	$45.07M	0.0%	+3,136.1%	1.810%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	64,981	$0.76M	0.0%	-15.6%	0.031%
11/17/2025	Jain Global LLC	15,925	$0.19M	0.0%	-18.9%	0.007%
11/17/2025	HighVista Strategies LLC	106,611	$1.25M	0.3%	+20.0%	0.050%
11/17/2025	Brevan Howard Capital Management LP	109,945	$1.29M	0.0%	+240.1%	0.052%
11/17/2025	Cantor Fitzgerald L. P.	201,865	$2.36M	0.0%	N/A	0.095%
11/17/2025	Bank of America Corp DE	447,116	$5.23M	0.0%	-41.1%	0.210%
11/17/2025	Alliancebernstein L.P.	3,424,439	$40.03M	0.0%	+2,003.2%	1.607%
11/17/2025	Ameriprise Financial Inc.	555,145	$6.49M	0.0%	+138.4%	0.261%
11/14/2025	Creative Planning	24,535	$0.29M	0.0%	+14.6%	0.012%
11/14/2025	Raymond James Financial Inc.	1,011,969	$11.83M	0.0%	+14.4%	0.475%
11/14/2025	Virtu Financial LLC	11,510	$0.14M	0.0%	N/A	0.005%
11/14/2025	Deep Track Capital LP	11,932,137	$139.49M	3.9%	-16.5%	5.601%
11/14/2025	California State Teachers Retirement System	100,264	$1.17M	0.0%	+12.2%	0.047%
11/14/2025	Acuta Capital Partners LLC	1,165,206	$13.62M	14.1%	+14.8%	0.547%
11/14/2025	Balyasny Asset Management L.P.	2,189,276	$25.59M	0.0%	+902.9%	1.028%
11/14/2025	Shay Capital LLC	84,500	$0.99M	0.1%	N/A	0.040%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	201,259	$2.35M	0.0%	-36.4%	0.094%
11/14/2025	Two Sigma Investments LP	234,213	$2.74M	0.0%	+111.3%	0.110%
11/14/2025	Squarepoint Ops LLC	350,758	$4.10M	0.0%	N/A	0.165%
11/14/2025	Avoro Capital Advisors LLC	10,250,000	$119.82M	1.5%	+38.5%	4.811%
11/13/2025	Marshall Wace LLP	1,601,449	$18.72M	0.0%	N/A	0.752%
11/13/2025	Rosalind Advisors Inc.	400,000	$4.68M	1.6%	-67.2%	0.188%
11/13/2025	Invesco Ltd.	1,043,896	$12.20M	0.0%	-32.2%	0.490%
11/13/2025	Sei Investments Co.	116,114	$1.36M	0.0%	-24.4%	0.055%
11/13/2025	UBS Group AG	1,248,266	$14.59M	0.0%	-36.5%	0.586%
11/13/2025	BNP Paribas Financial Markets	29,495	$0.35M	0.0%	-85.9%	0.014%
11/13/2025	Swiss National Bank	200,700	$2.35M	0.0%	+1.7%	0.094%
11/13/2025	Russell Investments Group Ltd.	13,823	$0.16M	0.0%	N/A	0.006%
11/13/2025	Rhenman & Partners Asset Management AB	202,000	$2.36M	0.3%	N/A	0.095%
11/13/2025	First Trust Advisors LP	339,631	$3.97M	0.0%	N/A	0.159%
11/12/2025	Aptus Capital Advisors LLC	402,467	$4.71M	0.0%	+4.4%	0.189%
11/12/2025	Barclays PLC	411,617	$4.81M	0.0%	-17.0%	0.193%
11/12/2025	Rafferty Asset Management LLC	16,571	$0.19M	0.0%	+23.5%	0.008%
11/12/2025	Fifth Lane Capital LP	17,000	$0.20M	0.2%	N/A	0.008%
11/12/2025	Artisan Partners Limited Partnership	1,076,382	$12.58M	0.0%	+1.0%	0.505%
11/12/2025	Intech Investment Management LLC	78,421	$0.92M	0.0%	-14.0%	0.037%
11/10/2025	Patient Square Capital LP	715,000	$8.36M	2.2%	-12.6%	0.336%
11/10/2025	Ameritas Investment Partners Inc.	11,744	$0.14M	0.0%	-18.2%	0.006%
11/10/2025	Citigroup Inc.	673,348	$7.87M	0.0%	+574.4%	0.316%
11/10/2025	China Universal Asset Management Co. Ltd.	60,499	$0.71M	0.1%	-2.4%	0.028%
11/7/2025	Levin Capital Strategies L.P.	15,000	$0.18M	0.0%	N/A	0.009%
11/7/2025	Summer Road LLC	12,579,657	$147.05M	98.3%	-9.4%	7.230%
11/7/2025	GSA Capital Partners LLP	115,553	$1.35M	0.1%	N/A	0.066%
11/7/2025	Vanguard Group Inc.	9,163,240	$107.12M	0.0%	+9.2%	5.266%
11/6/2025	Rhumbline Advisers	220,008	$2.57M	0.0%	-2.5%	0.126%
11/6/2025	Essex Investment Management Co. LLC	394,076	$4.61M	0.7%	+3.3%	0.226%
11/6/2025	Profund Advisors LLC	25,178	$0.29M	0.0%	+9.9%	0.014%
11/6/2025	ProShare Advisors LLC	30,235	$0.35M	0.0%	-13.1%	0.017%
11/4/2025	Allianz Asset Management GmbH	42,700	$0.50M	0.0%	-30.2%	0.025%
11/4/2025	Principal Financial Group Inc.	10,760	$0.13M	0.0%	N/A	0.006%
11/3/2025	AlphaQuest LLC	50,603	$0.59M	0.0%	+150.6%	0.029%
11/3/2025	New York State Common Retirement Fund	109,372	$1.28M	0.0%	+11.5%	0.063%
10/29/2025	Courier Capital LLC	136,266	$1.59M	0.1%	-11.7%	0.078%
10/28/2025	Campbell & CO Investment Adviser LLC	11,263	$0.13M	0.0%	N/A	0.006%
10/27/2025	RWC Asset Management LLP	16,241	$0.19M	0.0%	N/A	0.009%
10/24/2025	Deltec Asset Management LLC	2,762,459	$32.29M	5.3%	-1.2%	1.588%
10/23/2025	Peregrine Capital Management LLC	617,519	$7.22M	0.2%	-28.4%	0.355%
10/23/2025	SG Americas Securities LLC	55,496	$0.65M	0.0%	+431.8%	0.032%
10/15/2025	Vontobel Holding Ltd.	14,498	$0.17M	0.0%	-18.0%	0.008%
10/10/2025	RoundAngle Advisors LLC	176,800	$2.07M	1.6%	-4.8%	0.102%
10/9/2025	Voya Investment Management LLC	184,427	$2.16M	0.0%	-36.7%	0.106%
10/8/2025	Dudley & Shanley Inc.	13,000	$0.15M	0.0%	-20.7%	0.007%
10/7/2025	Assenagon Asset Management S.A.	45,600	$0.53M	0.0%	-76.5%	0.026%
10/7/2025	Union Bancaire Privee UBP SA	25,500	$0.30M	0.0%	N/A	0.015%
9/4/2025	Osaic Holdings Inc.	67,530	$0.63M	0.0%	+19,194.3%	0.039%
8/28/2025	China Universal Asset Management Co. Ltd.	61,995	$0.58M	0.1%	+96.6%	0.036%
8/19/2025	Marex Group plc	12,358	$0.12M	0.0%	N/A	0.007%
8/18/2025	Hudson Bay Capital Management LP	54,090	$0.50M	0.0%	N/A	0.031%
8/18/2025	Second Line Capital LLC	385,467	$3.58M	0.8%	+11.4%	0.222%
8/15/2025	CANADA LIFE ASSURANCE Co	27,185	$0.25M	0.0%	+127.0%	0.016%
8/15/2025	Tower Research Capital LLC TRC	36,297	$0.34M	0.0%	+883.9%	0.021%
8/15/2025	Rafferty Asset Management LLC	13,413	$0.12M	0.0%	+21.2%	0.008%
8/15/2025	Hudson Bay Capital Management LP	54,090	$0.50M	0.0%	N/A	0.031%
8/15/2025	BNP Paribas Financial Markets	208,530	$1.94M	0.0%	+282.7%	0.120%
8/15/2025	Brevan Howard Capital Management LP	32,328	$0.30M	0.0%	N/A	0.019%
8/15/2025	Balyasny Asset Management L.P.	218,293	$2.03M	0.0%	+187.7%	0.125%
8/15/2025	Bank of America Corp DE	759,260	$7.05M	0.0%	-19.4%	0.436%
8/15/2025	Adage Capital Partners GP L.L.C.	3,890,177	$36.10M	0.1%	-25.2%	2.236%
8/15/2025	Ameriprise Financial Inc.	232,886	$2.16M	0.0%	+241.8%	0.134%
8/14/2025	California State Teachers Retirement System	89,383	$0.83M	0.0%	-2.8%	0.051%
8/14/2025	Acuta Capital Partners LLC	1,014,940	$9.42M	13.1%	-16.8%	0.583%
8/14/2025	Raymond James Financial Inc.	884,381	$8.21M	0.0%	+142.8%	0.508%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	77,034	$0.72M	0.0%	-17.7%	0.044%
8/14/2025	The Manufacturers Life Insurance Company	72,618	$0.67M	0.0%	+1.8%	0.042%
8/14/2025	Sei Investments Co.	153,670	$1.43M	0.0%	+453.9%	0.088%

Data available starting January 2016

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $12.43

$11.41

$13.00

50 Day Range

MA: $11.63

$10.63

$12.53

52 Week Range

Now: $12.43

$5.78

$13.85

Volume

5,820,311 shs

Average Volume

2,330,914 shs

Market Capitalization

$2.65 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of Ocular Therapeutix?: Ocular Therapeutix's top insider investors include:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Antony C Mattessich (CEO)
Donald Notman (Insider)
Sanjay Nayak (Insider)
Jeffrey S Heier (Insider)
Peter Kaiser (Insider)
Richard L Md Lindstrom (Director)
Donald Notman (CFO)
Philip C Strassburger (General Counsel)
Rabia Gurses Ozden (Insider)
Todd Anderman (Insider)
Learn More about top insider investors at Ocular Therapeutix.
Who are the major institutional investors of Ocular Therapeutix?: Ocular Therapeutix's top institutional investors include:
Summer Road LLC — 7.23%
Deep Track Capital LP — 5.60%
Avoro Capital Advisors LLC — 4.81%
Vanguard Group Inc. — 5.27%
TCG Crossover Management LLC — 2.87%
Millennium Management LLC — 1.81%
Learn More about top institutional investors of Ocular Therapeutix stock.
Which major investors are selling Ocular Therapeutix stock?: In the previous quarter, OCUL stock was sold by these institutional investors:
Deep Track Capital LP
Summer Road LLC
Rosalind Advisors Inc.
UBS Group AG
Invesco Ltd.
Bank of America Corp DE
Peregrine Capital Management LLC
BNP Paribas Financial Markets
Within the last year, company insiders that have sold Ocular Therapeutix company stock include:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Antony C Mattessich (CEO)
Donald Notman (Insider)
Sanjay Nayak (Insider)
Jeffrey S Heier (Insider)
Learn More investors selling Ocular Therapeutix stock.
Which major investors are buying Ocular Therapeutix stock?: During the previous quarter, OCUL stock was acquired by institutional investors including:
Millennium Management LLC
Alliancebernstein L.P.
Avoro Capital Advisors LLC
Balyasny Asset Management L.P.
Marshall Wace LLP
Woodline Partners LP
TCG Crossover Management LLC
Vanguard Group Inc.
During the previous year, these company insiders have bought Ocular Therapeutix stock:
Summer Road Llc (Major Shareholder)
Pravin Dugel (Insider)
Learn More investors buying Ocular Therapeutix stock.